{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:46:43Z","timestamp":1761101203740,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.nmd.2013.11.005","type":"journal-article","created":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T12:00:18Z","timestamp":1384603218000},"page":"148-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Muscle-specific kinase antibody associated myasthenia gravis after bone marrow transplantation"],"prefix":"10.1016","volume":"24","author":[{"given":"Zeinab","family":"Heidarzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyyed-Asadollah","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid Reza","family":"Ostovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahriar","family":"Nafissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2013.11.005_b0005","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.bmt.1700759","article-title":"Myasthenia gravis in association with allogenic bone marrow transplantation: clinical observations, therapeutic implications and review of literature","volume":"19","author":"Mackey","year":"1997","journal-title":"Bone Marr Transpl"},{"key":"10.1016\/j.nmd.2013.11.005_b0010","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/mus.21023","article-title":"Muscle-specific kinase (MuSK) antibody-associated myasthenia gravis after bone marrow transplantation","volume":"38","author":"Atassi","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2013.11.005_b0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3988\/jcn.2009.5.2.53","article-title":"Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status","volume":"5","author":"Oh Sh","year":"2009","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.nmd.2013.11.005_b0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bmt.1701297","article-title":"Myasthenia gravis without chronic GVHD after allogenic bone marrow transplantation","volume":"2","author":"Baron","year":"1998","journal-title":"Bone Marr Transpl"},{"key":"10.1016\/j.nmd.2013.11.005_b0025","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.bmt.1702067","article-title":"Myasthenia gravis after allogenic bone marrow transplantation for lymphoblastic lymphoma","volume":"24","author":"Dowell","year":"1999","journal-title":"Bone Marr Transpl"},{"key":"10.1016\/j.nmd.2013.11.005_b0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1600-0609.2002.02789.x","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40_ CD4_ T cells","volume":"69","author":"Kotani","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.nmd.2013.11.005_b0035","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM198312223092508","article-title":"Myasthenia gravis after bone marrow transplantation. Evidence for a donor origin","volume":"309","author":"Smith","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2013.11.005_b0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1701575","article-title":"Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host disease","volume":"23","author":"Tse","year":"1999","journal-title":"Bone Marr Transpl"},{"key":"10.1016\/j.nmd.2013.11.005_b0045","first-page":"503","article-title":"A patient of chronic graft-versus-host disease presenting simultaneously with polymyositis and myasthenia gravis","volume":"41","author":"Yanagihara","year":"2001","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.nmd.2013.11.005_b0050","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/CND.0b013e31821c560e","article-title":"Muscle-specific kinase-antibody positive myasthenia gravis after autologous bone marrow transplantation","volume":"13","author":"Grover","year":"2012","journal-title":"Clin Neuromusc Dis"},{"key":"10.1016\/j.nmd.2013.11.005_b0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nmd.2013.11.005_b0060","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.bbmt.2012.05.014","article-title":"Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1\/Th17 differentiation","volume":"18","author":"Ma","year":"2012","journal-title":"Biol Blood Marr Transpl"},{"key":"10.1016\/j.nmd.2013.11.005_b0065","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/annonc\/mdm010","article-title":"Chronic myeloid leukemia presenting as paraneoplastic ocular myasthenia gravis","volume":"18","author":"Kumar","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nmd.2013.11.005_b0070","first-page":"649","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation: a case report","volume":"15","author":"Zaja","year":"1995","journal-title":"Bone Marr Transpl"},{"key":"10.1016\/j.nmd.2013.11.005_b0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0887-8994(94)00097-L","article-title":"Neuromuscular complications of bone marrow transplantation","volume":"12","author":"Adams","year":"1995","journal-title":"Pediat Neurol"},{"key":"10.1016\/j.nmd.2013.11.005_b0080","first-page":"155","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation","volume":"14","author":"Shimoda","year":"1994","journal-title":"Bone Marr Transpl"},{"key":"10.1016\/j.nmd.2013.11.005_b0085","first-page":"1390","article-title":"Immune complex glomerulonephritis, myasthenia gravis and compensated hypothyroidism in a patient following allogeneic bone marrow transplantation","volume":"8","author":"Haslam","year":"1993","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.nmd.2013.11.005_b0090","first-page":"78","article-title":"Myasthenia gravis after BMT: identification of patients at risk?","volume":"9","author":"Melms","year":"1992","journal-title":"Bone Marr Transpl"},{"key":"10.1016\/j.nmd.2013.11.005_b0095","first-page":"37","article-title":"Complicac\u00b8oes pouco habituais da transplantacao de medula ossea (TMO). Experie\u02c6ncia da Unidade de TMO do Instituo Portugue\u02c6s de Oncologia de Francisco Gentil, Centro de Lisboa","volume":"4","author":"Abecassis","year":"1991","journal-title":"Acta Med Portuguesa"},{"key":"10.1016\/j.nmd.2013.11.005_b0100","first-page":"435","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations","volume":"5","author":"Grau","year":"1990","journal-title":"Bone Marr Transpl"},{"key":"10.1016\/j.nmd.2013.11.005_b0105","first-page":"129","article-title":"Widespread pulmonary fibrosis as a major clinical manifestation of chronic graft-versus-host disease","volume":"4","author":"Atkinson","year":"1989","journal-title":"Bone Marr Transpl"},{"key":"10.1016\/j.nmd.2013.11.005_b0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJM198707163170314","article-title":"Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myasthenia gravis after bone marrow grafting","volume":"317","author":"Lefvert","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2013.11.005_b0115","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1212\/WNL.36.8.1087","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease","volume":"36","author":"Bolger","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2013.11.005_b0120","first-page":"221a","article-title":"Post bone marrow transplantation (BMT) myasthenia gravis: evidence for acetylcholine receptor (AChR) abnormality. Abstract","volume":"64","author":"Seely","year":"1984","journal-title":"Blood"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613009966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613009966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:02:03Z","timestamp":1760774523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896613009966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0960896613009966"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2013.11.005","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle-specific kinase antibody associated myasthenia gravis after bone marrow transplantation","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2013.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}